Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00729560 · ClinicalTrials.gov registry record · NA
Effects of Flutamide on Insulin and Glucose Metabolism in Women With Polycystic Ovary Syndrome
A NA study, sponsored by Virginia Commonwealth University.
- Terminated
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT00729560 is a NA study that was terminated before completion, run by Virginia Commonwealth University. The registered enrollment target is 8 participants.
The verdict
NCT00729560, a NA study, was terminated before completion, sponsored by Virginia Commonwealth University.
- TERMINATED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
Polycystic Ovary Syndrome (PCOS) is the major cause of infertility in the United States. Many women with PCOS demonstrate insulin resistance and a compensatory hyperinsulinemia.This is due to both an intrinsic form of insulin resistance unique to PCOS and, in many cases, acquired insulin resistance due to obesity. The importance of this observation lies in the fact that hyperinsulinemia appears to play an important pathogenetic role in the hyperandrogenism and anovulation of both obese and lean women with PCOS.
Interventions
- DRUG Placebo
- DRUG Flutamide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2008-07 |
| Est. Completion | 2012-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00729560
The ClinicalTrials.gov registry entry for NCT00729560 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00729560 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00729560 about?
NCT00729560 is a clinical study titled "Effects of Flutamide on Insulin and Glucose Metabolism in Women With Polycystic Ovary Syndrome". Polycystic Ovary Syndrome (PCOS) is the major cause of infertility in the United States. Many women with PCOS demonstrate insulin resistance and a compensatory hyperinsulinemia.This is due to both an intrinsic form of insulin resistance unique to PCOS and, in many cases, acquired insulin resistance ...
What is the current status of trial NCT00729560?
This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2008-07. Estimated completion is 2012-02.
What interventions are being tested in trial NCT00729560?
The interventions under investigation include: Placebo (DRUG), Flutamide (DRUG).
Who is sponsoring clinical trial NCT00729560?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.